The association of cervicovaginal Langerhans cells with clearance of human papillomavirus
Authors:
Open Access
- 12 October 2022
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 13, 918190
Abstract
Human papillomavirus (HPV) clearance is important in eliminating cervical cancer which contributes to high morbidity and mortality in women. Nevertheless, it remains largely unknown about key players in clearing pre-existing HPV infections. HPV antigens can be detected by the most important cervical antigen-presenting cells (Langerhans cells, LCs), of which the activities can be affected by cervicovaginal microbiota. In this review, we first introduce persistent HPV infections and then describe HPV-suppressed LCs activities, including but not limited to antigen uptake and presentation. Given specific transcriptional profiling of LCs in cervical epithelium, we also discuss the impact of cervicovaginal microbiota on LCs activation as well as the promise of exploring key microbial players in activating LCs and HPV-specific cellular immunity.Keywords
This publication has 140 references indexed in Scilit:
- Comparison of the vaginal microbiota diversity of women with and without human papillomavirus infection: a cross-sectional studyBMC Infectious Diseases, 2013
- Association of the Vaginal Microbiota with Human Papillomavirus Infection in a Korean Twin CohortPLOS ONE, 2013
- Functional diversity of human vaginal APC subsets in directing T-cell responsesMucosal Immunology, 2012
- Human papillomavirus type 16 E6 and E 7 proteins alter NF-kB in cultured cervical epithelial cells and inhibition of NF-kB promotes cell growth and immortalizationVirology, 2012
- Identification of Key Amino Acid Residues That Determine the Ability of High Risk HPV16-E7 to Dysregulate Major Histocompatibility Complex Class I ExpressionJournal of Biological Chemistry, 2011
- Persistence of human papillomavirus infection: keys to malignant progressionTrends in Microbiology, 2011
- Vaginal microbiome of reproductive-age womenProceedings of the National Academy of Sciences of the United States of America, 2010
- Phase II trial of imiquimod and HPV therapeutic vaccination in patients with vulval intraepithelial neoplasiaBritish Journal of Cancer, 2010
- Epigenetic repression of E-cadherin by human papillomavirus 16 E7 proteinCarcinogenesis, 2010
- Robust production and passaging of infectious HPV in squamous epithelium of primary human keratinocytesGenes & Development, 2009